Invited Speaker: Improving the Bioavailability of Topically and Transdermally Delivered Drugs

Richard H. Guy1
1University of Bath, Department of Pharmacy & Pharmacology, Claverton Down, Bath, BA2 7AY, U.K.


The delivery of drugs into and through the skin either for dermatological therapy, the treatment of local, subcutaneous inflammation, or to alleviate systemic disease, will always represent a major challenge. Despite significant progress in understanding skin barrier function, and the development of novel technologies for transdermal applications, there remain several research questions related to topical bioavailability that need to be addressed.

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link |
Admin Access